News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Bristol-Myers Squibb Company Continues Excellent Financial Performance Led By Double-Digit Global Net Sales Growth and Strong Earnings Results
October 23, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY): Reports Broad-Based Net Sales Growth of 14% from Continuing Operations
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Bristol Myers Squibb Company
MORE ON THIS TOPIC
Drug Development
Can Saudi Arabia’s burgeoning biotech hub withstand geopolitical pressures?
November 2, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Layoff Tracker
Immutep, Molecular cut workforces
October 30, 2026
·
113 min read
·
BioSpace Editorial Staff
Earnings
AstraZeneca employs $1.5B cost savings to reinvest back into growth
October 30, 2026
·
3 min read
·
Annalee Armstrong
Earnings
Regeneron achieves ‘clean sweep’ in Q3 with myriad pipeline catalysts on deck
October 30, 2026
·
4 min read
·
Heather McKenzie
